extract: 2026-01-01-frontiers-social-prescribing-health-economics-systematic-review
Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>
This commit is contained in:
parent
238cbeb924
commit
355174bc55
2 changed files with 41 additions and 1 deletions
|
|
@ -0,0 +1,24 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "social-prescribing-produces-social-value-but-not-healthcare-cost-savings.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 1,
|
||||
"kept": 0,
|
||||
"fixed": 1,
|
||||
"rejected": 1,
|
||||
"fixes_applied": [
|
||||
"social-prescribing-produces-social-value-but-not-healthcare-cost-savings.md:set_created:2026-03-18"
|
||||
],
|
||||
"rejections": [
|
||||
"social-prescribing-produces-social-value-but-not-healthcare-cost-savings.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -7,10 +7,14 @@ date: 2026-01-01
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: paper
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: medium
|
||||
triage_tag: claim
|
||||
tags: [social-prescribing, health-economics, cost-effectiveness, evidence-quality, international-health-systems]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-18
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "LLM returned 1 claims, 1 rejected by validator"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -51,3 +55,15 @@ Complementary evidence on healthcare utilization (from separate reviews):
|
|||
## Curator Notes
|
||||
PRIMARY CONNECTION: social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem
|
||||
WHY ARCHIVED: Provides the economic evidence (or lack thereof) for social prescribing, the most scaled non-clinical health intervention globally. The SROI/financial ROI divergence is a key finding for understanding which behavioral health interventions can scale under healthcare payment models.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Social prescribing systematic review included 18 studies: 5 RCTs, 1 quasi-experimental, 12 mixed-methods
|
||||
- Geographic coverage: England, Wales, Ireland, Europe, Australia, New Zealand, Canada, USA
|
||||
- Intervention types: exercise/loneliness prevention (n=10), coaching (n=3), nature-based (n=3), dance/movement (n=2)
|
||||
- SROI ratios ranged from £1.17 to £7.08 per £1 invested
|
||||
- Financial ROI ranged from 0.11 to 0.43 per £1 invested
|
||||
- 28% average reduction in GP demand (range: 2-70%)
|
||||
- 24% average reduction in A&E attendance (range: 8-27%)
|
||||
- 15 of 17 utilization studies were uncontrolled before-and-after designs
|
||||
- Mean attrition rate across studies: 38%
|
||||
|
|
|
|||
Loading…
Reference in a new issue